The most striking finding in recent oncological research is the significant gain in survival rates for cancers previously ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Providence Cancer Institute’s executive medical director ...

The five-year survival rate for all cancers combined in the US reached a landmark 70% for Americans diagnosed between 2015 ...

Then you have the fact that clinical trials often underrepresent minorities. This can lead to skewed AI models, with 80 ...

In 1970, only half of patients lived past five years. Now, at least 70 percent of U.S. cancer patients are surviving for at ...

Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall response rate in treatment-naive patients. Discover the latest ...

VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – The FDA approved the first perioperative immunotherapy for early gastric and gastroesophageal ...

Picture this: a breast cancer diagnosis that once meant endless cycles of harsh chemotherapy, now shifting toward smarter, more targeted therapies that attack cancer cells while sparing healthy ones.

Cancer diagnoses are both more common and more survivable than ever. The question is whether you can afford life-saving ...

Since 2018, more than $40 million has been granted to support outstanding cancer research projects by early-career scientists ...

The government is investing in technology and AI to spot cancers earlier in a bid to end the postcode lottery of care for cancer patients.

Few issues in American politics have consistently united both parties like the fight against cancer. While funding levels and strategies may differ, Democrats and Republicans alike recognize that ...